2018•Archives of Cardiovascular Diseases SupplementsOpen access

The efficacy and safety of apixaban versus warfarin are preserved in patients with atrial fibrillation and extreme body weight: Insights from the ARISTOTLE Study

Marat Fudim, Renato D. Lópes, John Hunter Alexander, DANIEL M. WOJDYLA, Justin Adrian Ezekowitz, Michael Hanna, Dan Atar, Ziad Hijazi, Maria Cecilia Bahit, Jose Luis Lopez-Sendon, Lars C. Wallentin, Christopher Bull Granger, Stefan Hans Hohnloser

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Apixaban, Atrial fibrillation, Warfarin, Internal medicine, Stroke (engine), Randomized controlled trial, Clinical endpoint